WO1996037184A2 - Körperdeodorans - Google Patents
Körperdeodorans Download PDFInfo
- Publication number
- WO1996037184A2 WO1996037184A2 PCT/EP1996/002108 EP9602108W WO9637184A2 WO 1996037184 A2 WO1996037184 A2 WO 1996037184A2 EP 9602108 W EP9602108 W EP 9602108W WO 9637184 A2 WO9637184 A2 WO 9637184A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- deodorant
- body deodorant
- alkyl
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Definitions
- the invention relates to aqueous preparations for body deodorization which are liquid, clear or transparent and stable to cold and largely or completely free of volatile solvents.
- Preparations for body deodorization are usually offered as stick preparations, roll-on formulations or as aerosol sprays. Products that are packaged in roll-on containers or in pump sprays without aerosol propellant are increasingly preferred. So far, mainly alcoholic and aqueous-alcoholic preparations with relatively high contents of lower alcohols have been used for this purpose.
- the object was therefore to propose an aqueous, liquid deodorant which is clear or transparent and stable to cold and largely or completely free of volatile solvents.
- This object was achieved according to the invention by an aqueous body deodorant which contains a deodorant active ingredient in an aqueous carrier which contains water as carrier components and (based on the entire deodorant) 10 to 20% by weight of a water-soluble polyol from the group of Polyols with 2 to 9 carbon atoms and 2 to 6 hydroxyl groups and the polyether polyols with molecular weights up to 1000, which can be obtained by adding ethylene oxide and / or propylene oxide to such polyols, and 0.1 to 10% by weight of a water-soluble one Contains surfactant and whose pH is adjusted to a value between 3 and 6.
- An aqueous body deodorant is preferably understood to mean a preparation which contains less than 5% by weight of volatile solvents, in particular less than 5% by weight of lower alcohols with 1 to 3 C atoms.
- the body deodorant according to the invention is preferably free of volatile solvents.
- Suitable water-soluble polyols are e.g. Ethylene glycol, propylene glycol, glycerol, diethylene glycol, diglycerol, sorbitol, methyl glucoside, butyl glucoside, adducts of 10 to 20 mol ethylene oxide with methyl glucoside or butyl glucoside, polyglycerol, polyethylene glycols and adducts of ethylene glycol with polypropylene. All polyols or polyether polyols which are clearly soluble in water at 20 ° C. at 20 ° C. and thereby form liquid solutions are understood to be water-soluble.
- 1,2-propylene glycol is contained as water-soluble polyol in the body deodorants according to the invention. Mixtures of the polyols mentioned can also be used.
- any surfactant which has a water solubility of at least 1% by weight in water at 20 ° C. can be used as the water-soluble surfactant.
- nonionic surfactants are particularly preferred because of their good emulsifying and solubilizing properties, certain antimicrobial agents may lose their effectiveness.
- the glycoside residue is preferably derived from glucose.
- Alkyl glycosides their preparation and use as surface-active substances are known, for example, from DE 1943689 or from DE 3827 543. They are produced, for example, by reacting glucose or oligosaccharides with primary alcohols with 8 to 22 carbon atoms or by transacetalizing starch with e.g. lower alcohols and renewed acetalization with the Cß - ⁇ - fatty alcohol.
- the glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 10 are suitable.
- the average degree of oligomerization results from the molar proportions of the individual oligomers by dividing the sum of the structural units by the sum of the molecules (cf. Principles of Polymer Chemistry, Paul J. Flory, Cornell University Press, Ithaca, New York 1953, page 35 - 36).
- alkyl (oligo) glycosides in the deodorants according to the invention even leads to a synergistically increased deodorant effect in numerous deodorant active ingredients, for example in cationic compounds and in the bis-biguanides (for example chlorhexidine gluconate), which allows such deodorant Use active ingredients in particularly low and physiologically better tolerated concentrations.
- deodorant active ingredients for example in cationic compounds and in the bis-biguanides (for example chlorhexidine gluconate), which allows such deodorant Use active ingredients in particularly low and physiologically better tolerated concentrations.
- alkyl glycosides but preferably in addition to these, other surface-active substances can also be used, but the concentration of surfactants should preferably not exceed 10% by weight, their concentration should rather be as low as possible and only as high as for stable emulsification of the Deodorant active ingredients and possibly the fragrances are kept necessary.
- Suitable co-surfactants are, above all, nonionic surfactants, for example addition products of ethylene oxide onto fatty alcohols, fatty acids, fatty acid partial glycerides, sorbitan fatty acid esters or methyl glucoside fatty acid esters.
- suitable nonionic co-surfactants are, for example, ethoxylated castor oil or fatty acid esters of glycerol ethoxylates (for example Cetiol ( R ) HE, Henkel KGaA).
- all substances known for this purpose can be used as deodorizing active substances, which inhibit the microbial sweat decomposition on the skin due to their antimicrobial or esterase-inhibiting effect.
- astringent substances which counteract sweat formation on the skin can also be used.
- astringent compounds which are germ-inhibiting even in low concentrations and antiperspirant in higher concentrations are e.g. the strongly hydrolyzing aluminum, zinc and zirconium salts in the aqueous medium.
- esterase-inhibiting deodorant active ingredients are e.g. the esters of hydroxycarboxylic acids such as e.g. Ethyl lactate or triethyl citrate.
- suitable active substances of this type are e.g. the ester compounds known from DE-A-4343264 and DE-A-4343265.
- Known antimicrobial deodorant active ingredients are, for example, the salts of benzoic acid, p-hydroxybenzoic acid, and salicylic acid Usnic acid or undecylenic acid.
- Further suitable deodorant active ingredients are benzyl alcohol, 2-phenylethanol, phenoxyethanol, farnesol, glycerol monoalkyl (Cg-Ci6) ether and diglycerol monoalkyl
- Antimicrobial and esterase-inhibiting deodorant active ingredients are preferred for carrying out the invention in an amount of 0.1 to 2% by weight.
- a preferred group of antimicrobial and deodorant compounds is that of the quaternary ammonium compounds, the bis-biguanides, e.g. Chlorhexidine, and the polybiguanides.
- the betaines and the cationic phospholipids are particularly suitable for use in the body deodorants according to the invention.
- the cationic phospholipids of formula II known from WO 93/25185 as active deodorants are suitable,
- Anion which forms a water-soluble ammonium salt is to be understood as a "water-soluble" anion.
- A is preferably a halide, for example a chloride or bromide anion.
- the body deodorants according to the invention preferably contain a weak acid such as, for example, lactic acid, citric acid, tartaric acid or glycolic acid or a buffer system composed of such acids and small amounts of the alkali metal salts of such acids to set a pH of 3 to 6.
- Deodorising preparations preferably also contain a fragrance which can be added in amounts of 0.1 to 2% by weight.
- fragrances can also be dispensed with if e.g. an antimicrobial essential oil or an antimicrobial deodorant active ingredient with a pleasant odor such as e.g. Phenylethyl alcohol or hydrozalkohol or a mixture is used, such as e.g. is known from DE-A-4 124664.
- the body deodorants according to the invention are liquid, i.e. at 20 ° C. they should have a viscosity which is below 1000 [m-Pa-s] (measured with a rotary viscometer at a low shear rate). They are then particularly well suited for use in so-called roller ball application containers or pump atomizers.
- the viscosity should preferably be in the range from 500 to 1000 [m ⁇ Pa-s] at 20 ° C, which may be achieved by adding water-soluble thickeners, e.g. of natural microbial or synthetic water-soluble polymers such as e.g. water-soluble starch, guar, xanthan gum, hydroxyethyl cellulose, hydroxypropyl starch, polyacrylamide, polyvinylpyrrolidone, polyvinyl alcohol or jittery polyacrylates (e.g. of the Carbopol (R) type) can be achieved.
- water-soluble thickeners e.g. of natural microbial or synthetic water-soluble polymers such as e.g. water-soluble starch, guar, xanthan gum, hydroxyethyl cellulose, hydroxypropyl starch, polyacrylamide, polyvinylpyrrolidone, polyvinyl alcohol or jittery polyacrylates (e.g. of the Carbopol (R) type
- the viscosity should be lower, preferably less than 500 m Pa 's (20 ° C).
- the body deodorants according to the invention can also contain other auxiliaries and additives customary in such preparations. Such tools are, for example
- Antioxidants e.g. Butylated hydroxyanisole, butylated hydroxytoluene, tocopherols or tocopherol esters
- Complexing agents e.g. Ethylene diamine tetraacetic acid salts, nitrilotriacetic acid salts, sodium citrate
- Skin cosmetic agents e.g. Oil components, fats, waxes, paraffins, silicones in small amounts of up to 2% by weight of the preparation
- Aids to convey a feeling of freshness on the skin e.g. Menthol or mentyl lactate
- Body deodorants were produced according to the following recipes:
- 1,2-propylene glycol 15.0 15.0 15.0 15.0 15.0 15.0 15.0 15.0 12.0 15.0
- Ci2-Ci6-Al yl glucoside, n 1.4 2.0 2.0 - - - - 2.0 - 1.0 hydr.
- the products are suitable for use from pump spray cans (without aerosol propellant).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96917381A EP0828476A2 (de) | 1995-05-26 | 1996-05-17 | Körperdeodorans |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19519404.7 | 1995-05-26 | ||
DE1995119404 DE19519404A1 (de) | 1995-05-26 | 1995-05-26 | Körperdeodorans |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996037184A2 true WO1996037184A2 (de) | 1996-11-28 |
WO1996037184A3 WO1996037184A3 (de) | 1997-01-23 |
Family
ID=7762973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/002108 WO1996037184A2 (de) | 1995-05-26 | 1996-05-17 | Körperdeodorans |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0828476A2 (de) |
DE (1) | DE19519404A1 (de) |
WO (1) | WO1996037184A2 (de) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010028420A1 (de) | 2010-04-30 | 2011-11-03 | Henkel Ag & Co. Kgaa | Deo-Schäume |
US9687425B2 (en) | 2014-06-30 | 2017-06-27 | The Procter & Gamble Company | Personal care compositions and methods |
US9717930B2 (en) | 2013-03-12 | 2017-08-01 | The Procter & Gamble Company | Antiperspirant compositions |
US9877909B2 (en) | 2014-06-30 | 2018-01-30 | The Procter & Gamble Company | Personal care compositions and methods |
US10016343B2 (en) | 2013-03-12 | 2018-07-10 | The Procter & Gamble Company | Solid stick antiperspirant compositions |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19917743C2 (de) * | 1999-04-20 | 2003-08-14 | Biotec Asa | Desodorierende Zubereitungen |
DE19924496A1 (de) * | 1999-05-28 | 2000-11-30 | Wella Ag | Desodorierende Wirkstoffkombination und deren Verwendung |
WO2005105026A1 (de) | 2004-04-27 | 2005-11-10 | Beiersdorf Ag | Transparente kosmetische oder dermatologische formulierung |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4305996C1 (de) * | 1993-02-26 | 1994-03-31 | Goldwell Ag | Mittel zum Verformen von menschlichen Haaren |
-
1995
- 1995-05-26 DE DE1995119404 patent/DE19519404A1/de not_active Withdrawn
-
1996
- 1996-05-17 WO PCT/EP1996/002108 patent/WO1996037184A2/de not_active Application Discontinuation
- 1996-05-17 EP EP96917381A patent/EP0828476A2/de not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4305996C1 (de) * | 1993-02-26 | 1994-03-31 | Goldwell Ag | Mittel zum Verformen von menschlichen Haaren |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011134747A2 (de) | 2010-04-30 | 2011-11-03 | Henkel Ag & Co. Kgaa | Deo-schäume |
WO2011134747A3 (de) * | 2010-04-30 | 2013-04-18 | Henkel Ag & Co. Kgaa | Deo-schäume |
DE102010028420A1 (de) | 2010-04-30 | 2011-11-03 | Henkel Ag & Co. Kgaa | Deo-Schäume |
US9937113B2 (en) | 2013-03-12 | 2018-04-10 | The Procter & Gamble Company | Antiperspirant compositions |
US9717930B2 (en) | 2013-03-12 | 2017-08-01 | The Procter & Gamble Company | Antiperspirant compositions |
US10052271B2 (en) | 2013-03-12 | 2018-08-21 | The Procter & Gamble Company | Antiperspirant compositions |
US10016343B2 (en) | 2013-03-12 | 2018-07-10 | The Procter & Gamble Company | Solid stick antiperspirant compositions |
US9687425B2 (en) | 2014-06-30 | 2017-06-27 | The Procter & Gamble Company | Personal care compositions and methods |
US9877909B2 (en) | 2014-06-30 | 2018-01-30 | The Procter & Gamble Company | Personal care compositions and methods |
US9750671B2 (en) | 2014-06-30 | 2017-09-05 | The Procter & Gamble Company | Personal care compositions and methods |
US10154949B2 (en) | 2014-06-30 | 2018-12-18 | The Procter & Gamble Company | Personal care compositions and methods |
US10413493B2 (en) | 2014-06-30 | 2019-09-17 | The Procter & Gamble Company | Personal care composition and methods |
US10716743B2 (en) | 2014-06-30 | 2020-07-21 | The Procter & Gamble Company | Personal care compositions and methods |
Also Published As
Publication number | Publication date |
---|---|
EP0828476A2 (de) | 1998-03-18 |
DE19519404A1 (de) | 1996-11-28 |
WO1996037184A3 (de) | 1997-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69403082T2 (de) | Wässrige alkoholische kosmetische mikroemulsionen | |
DE602004010822T2 (de) | Wässrige alkoholische antiperspirans-zusammensetzung mit einem calciumverstärkten antiperspirans-salz | |
DE2939519A1 (de) | Kosmetikpraeparat | |
JPH05194144A (ja) | 固体ゲルの形の化粧料組成物及びその製造方法 | |
DE69736052T2 (de) | Flüssige hererische Polyoxyalkylenverbindungen mit verbesserten Fliessverhalten | |
WO1996037184A2 (de) | Körperdeodorans | |
EP1704897B1 (de) | Schäumbare kosmetische Zusammensetzungen | |
EP0623338B1 (de) | Zusammensetzung für einen durchsichtigen kosmetischen Stift der Natriumsalz des Methyl-Carboxylderivates des ethoxylierten Laurylalkoholes enthält | |
AU740042B2 (en) | Oral and dental hygiene products for sensitive teeth | |
DE10007321A1 (de) | Reinigungsschaum | |
EP2033622B1 (de) | Kosmetisches Reinigungsmittel mit niedrigem pH | |
WO2008064948A1 (de) | Stabilisierte mundwässer und mundwasserkonzentrate enthaltend cyclodextrin (derivat) | |
JP2004035458A (ja) | 透明液状化粧料 | |
DE102016221155A1 (de) | Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen | |
DE3015450A1 (de) | Antitranspirationsmittel | |
EP1040757B1 (de) | Antiseptisches/fungizides Mittel und endermatische Salbe, die es enthalten | |
JP3323826B2 (ja) | 化粧品組成物 | |
JP2002226355A (ja) | シート状化粧料用液状組成物及びそれを含浸させたシート状化粧料 | |
JPH09263514A (ja) | 皮膚外用剤 | |
DE10047759A1 (de) | Feuchte Deodoranttücher | |
DE69500114T2 (de) | Präparate mit einem Schleifmittel- und einem Tensid-System | |
DE2524364A1 (de) | Antitranspirant in aerosolform | |
DE2432484A1 (de) | Kosmetisches mittel | |
DE102021203720A1 (de) | Klare, hautverträgliche Deodorantien oder Antitranspirantien | |
DE102019133191A1 (de) | Lösliche Oligomere von Propandiol als Wirkstoff zur Regulierung der Schweißsekretion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CN JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CN JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996917381 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996917381 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996917381 Country of ref document: EP |